Brigham and Women's Hospital
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
Inclusion Criteria: * Patients aged between 40-75 with prior chest CT within last 3 years Exclusion Criteria: * Prior coronary artery disease * Prior cancer * Other life-limiting condition
The intervention involves electronic health record, email, or letter notification about the presence of coronary artery calcification on chest CT and recommendation of preventive therapy. This is based on results of the automatic detection of coronary artery calcification from AI device (software).
Arctuva estimate
Verify or correct the compensation shown for this listing.